Literature DB >> 14712185

Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction.

Jun Koyama1, Ravin Davidoff, Rodney H Falk.   

Abstract

OBJECTIVE: This study was performed to clarify whether the longitudinal myocardial velocity gradient could give new insights into the features of congestive heart failure in patients with primary amyloidosis.
METHODS: A total of 33 consecutive patients with biopsy specimen-proven primary amyloidosis were examined by pulsed Doppler tissue imaging.
RESULTS: In all, 22 had evidence of heart involvement, of whom 11 had clinical congestive heart failure. Sample volumes were placed on basal and midventricle in the apical 2- and 4-chamber views. Peak systolic, and peak early and late diastolic wall-motion velocities were measured at each site. Longitudinal myocardial velocity gradients were calculated as the difference between basal and midmyocardial velocities. Single-point analysis of pulsed Doppler tissue imaging could not distinguish any difference among groups, whereas the longitudinal myocardial velocity gradients in systole and early diastole were significantly impaired in the patients with congestive heart failure compared with both the patients without cardiac involvement and those with cardiac amyloidosis without congestive heart failure.
CONCLUSION: Longitudinal myocardial velocity gradient is a sensitive method for detecting systolic and diastolic dysfunction in cardiac amyloidosis and is superior to single-point analysis Doppler tissue imaging.

Entities:  

Mesh:

Year:  2004        PMID: 14712185     DOI: 10.1016/j.echo.2003.09.014

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  16 in total

Review 1.  The role of echocardiographic deformation imaging in hypertrophic myopathies.

Authors:  Maja Cikes; George R Sutherland; Lisa J Anderson; Bart H Bijnens
Journal:  Nat Rev Cardiol       Date:  2010-05-11       Impact factor: 32.419

2.  A rare cause of cardiac decompensation in a patient with left ventricular hypertrophy.

Authors:  Norman Mangner; Matthias Gutberlet; Karin Klingel; Reinhard Kandolf; Gerhard Schuler; Axel Linke
Journal:  Clin Res Cardiol       Date:  2012-05-30       Impact factor: 5.460

Review 3.  Use of tissue Doppler imaging to identify and manage systemic diseases.

Authors:  Frank Weidemann; Joerg M Strotmann
Journal:  Clin Res Cardiol       Date:  2007-08-29       Impact factor: 5.460

Review 4.  Transthyretin-related amyloidoses and the heart: a clinical overview.

Authors:  Claudio Rapezzi; Candida Cristina Quarta; Letizia Riva; Simone Longhi; Ilaria Gallelli; Massimiliano Lorenzini; Paolo Ciliberti; Elena Biagini; Fabrizio Salvi; Angelo Branzi
Journal:  Nat Rev Cardiol       Date:  2010-05-18       Impact factor: 32.419

5.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

Review 6.  Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging.

Authors:  Dalia Di Nunzio; Antonino Recupero; Cesare de Gregorio; Concetta Zito; Scipione Carerj; Gianluca Di Bella
Journal:  Curr Cardiol Rep       Date:  2019-02-12       Impact factor: 2.931

Review 7.  Illustrative review of cardiac amyloidosis by multimodality imaging.

Authors:  Hidekazu Tanaka
Journal:  Heart Fail Rev       Date:  2022-04-26       Impact factor: 4.214

8.  Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis.

Authors:  Raymond Q Migrino; Ravi K Mareedu; Daniel Eastwood; Mark Bowers; Leanne Harmann; Parameswaran Hari
Journal:  J Am Soc Echocardiogr       Date:  2009-10-31       Impact factor: 5.251

Review 9.  Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.

Authors:  James A White; Nowell M Fine
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

10.  Impact of regional left ventricular function on outcome for patients with AL amyloidosis.

Authors:  Dan Liu; Kai Hu; Markus Niemann; Sebastian Herrmann; Maja Cikes; Stefan Störk; Meinrad Beer; Philipp Daniel Gaudron; Caroline Morbach; Stefan Knop; Eva Geissinger; Georg Ertl; Bart Bijnens; Frank Weidemann
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.